Safety, Performance of CEREGLIDE 92 Intermediate Catheter in Treatment of Acute Ischemic Stroke - Trial NCT06386289
Access comprehensive clinical trial information for NCT06386289 through Pure Global AI's free database. This phase not specified trial is sponsored by Cerenovus, Part of DePuy Synthes Products, Inc. and is currently Not yet recruiting. The study focuses on Acute Ischemic Stroke. Target enrollment is 172 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Cerenovus, Part of DePuy Synthes Products, Inc.
Timeline & Enrollment
N/A
Sep 01, 2024
Jun 30, 2026
Primary Outcome
First pass reperfusion
Summary
The device is indicated for use in the revascularization of patients with acute ischemic
 stroke secondary to intracranial large vessel occlusive disease
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06386289
Device Trial